Maduck Sean bought CORT

October 1, 2026 · Form 4 insider transaction

Maduck Sean bought 413 shares of Corcept Therapeutics Incorporated at $8.27 per share, a transaction worth $3.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
413
Price
$8.27
Total value
$3.4K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after10,351
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

View the original Form 4 on SEC EDGAR